A fun and, dare I say, educational event hosted by Silicon Flatirons tonight featuring Todd Vernon and Walter Knapp, the CEO and COO respectively of Lijit . This is part of the Entrepreneurs Unplugged series, a chance to introduce local Boulder...
Topics: Boulder, Lijit, social networks, web 2.0

{"title":"Lijit Unplugged","post_url":"http:\/\/www.steveconnolly.com\/blog\/2008\/10\/lijit-unplugged.html","feed_url":"http:\/\/feeds.feedburner.com\/steveconnolly\/VuIF","author":"stconnolly","date":"2008-10-23 22:42:00","summary":"A fun and, dare I say, educational event hosted by Silicon Flatirons tonight featuring Todd Vernon and Walter Knapp, the CEO and COO respectively of Lijit . This is part of the Entrepreneurs Unplugged series, a chance to introduce local Boulder..."}

In a recent press release , Medco Health Solutions announced that it is partnering with the FDA to study the applicability of personalized medicine methodologies to prescription drug treatment. Medco is the nation’s leading pharmacy benefit manager...
Topics: fda, pharmacogenomics, warfarin

{"title":"Personalized Medicine at Medco","post_url":"http:\/\/www.steveconnolly.com\/blog\/2008\/08\/personalized-medicine-at-medco.html","feed_url":"http:\/\/feeds.feedburner.com\/steveconnolly\/VuIF","author":"stconnolly","date":"2008-08-21 16:47:00","summary":"In a recent press release , Medco Health Solutions announced that it is partnering with the FDA to study the applicability of personalized medicine methodologies to prescription drug treatment. Medco is the nation\u2019s leading pharmacy benefit manager..."}

Kudos to Adam Rubenstein , blogger extraordinaire , for landing a plum job at cutting edge pharmacogenomic firm ARCA biopharma . In addition to typing his fingers to the bone on seventeen blogs, Adam has been raising money for Fitzsimons BioBusiness...
Topics: Adam Rubenstein, ARCA Discovery, FBBp

{"title":"Adam\u2019s Next Big Venture","post_url":"http:\/\/www.steveconnolly.com\/blog\/2008\/06\/adams-next-big-venture.html","feed_url":"http:\/\/feeds.feedburner.com\/steveconnolly\/VuIF","author":"stconnolly","date":"2008-06-25 22:25:00","summary":"Kudos to Adam Rubenstein , blogger extraordinaire , for landing a plum job at cutting edge pharmacogenomic firm ARCA biopharma . In addition to typing his fingers to the bone on seventeen blogs, Adam has been raising money for Fitzsimons BioBusiness..."}

Retiring CEO of GlaxoSmithKline Jean-Pierre Garnier has published his thoughts on the shifting pharmaceutical business model in this month's Harvard Business Review . True to his roots, Garnier advocates returning the management of R&D to the...
Topics: blockbuster, drug development, GlaxoSmithKline

{"title":"The Progressive Blockbuster","post_url":"http:\/\/www.steveconnolly.com\/blog\/2008\/05\/progressive-blockbuster.html","feed_url":"http:\/\/feeds.feedburner.com\/steveconnolly\/VuIF","author":"stconnolly","date":"2008-05-22 14:46:00","summary":"Retiring CEO of GlaxoSmithKline Jean-Pierre Garnier has published his thoughts on the shifting pharmaceutical business model in this month's Harvard Business Review . True to his roots, Garnier advocates returning the management of R&D to the..."}

Put off by the unfulfilled hype of Web 2.0, some in the knowledge management community are now clamoring for Web 3.0 . Dr. David J. Roberts, Chief Scientist at iBASEt , writes in Oracle's Profit Online that Web 2.0 technologies aren't really...
Topics: semantic web, web 2.0

{"title":"The Promises of Web 3.0","post_url":"http:\/\/www.steveconnolly.com\/blog\/2008\/05\/promises-of-web-30.html","feed_url":"http:\/\/feeds.feedburner.com\/steveconnolly\/VuIF","author":"stconnolly","date":"2008-05-14 17:08:00","summary":"Put off by the unfulfilled hype of Web 2.0, some in the knowledge management community are now clamoring for Web 3.0 . Dr. David J. Roberts, Chief Scientist at iBASEt , writes in Oracle's Profit Online that Web 2.0 technologies aren't really..."}